Skip to main content
Journal ArticleOPEN ACCESS

Response of conventional chondrosarcoma to gemcitabine alone: a case report

  • Provenzano S
  • Hindi N
  • Morosi C
  • et al.
Clinical Sarcoma Research (2015) 5(1)
DOI: 10.1186/s13569-015-0025-z
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Conventional skeletal chondrosarcoma is a bone neoplasm, which is poorly sensitive to anthracyclines-based chemotherapy. We report on an 18-month-long tumour response to gemcitabine as single agent in a young patient with an advanced secondary peripheral conventional chondrosarcoma, previously treated unsuccessfully with anthracyclines, ifosfamide, platinum, etoposide.

Cite

CITATION STYLE

APA

Provenzano, S., Hindi, N., Morosi, C., Ghilardi, M., Collini, P., Casali, P. G., & Stacchiotti, S. (2015). Response of conventional chondrosarcoma to gemcitabine alone: a case report. Clinical Sarcoma Research, 5(1). https://doi.org/10.1186/s13569-015-0025-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free